Eric I Richman - Net Worth and Insider Trading
Eric I Richman Net Worth
The estimated net worth of Eric I Richman is at least $1 Million dollars as of 2024-11-13. Eric I Richman is the Director of ADMA Biologics Inc and owns about 36,530 shares of ADMA Biologics Inc (ADMA) stock worth over $795,623. Eric I Richman is the Director of Gain Therapeutics Inc and owns about 304,458 shares of Gain Therapeutics Inc (GANX) stock worth over $631,750. Eric I Richman is also the Director of NeuBase Therapeutics Inc and owns about 3,635 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $1,374. Details can be seen in Eric I Richman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric I Richman has not made any transactions after 2024-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric I Richman
Eric I Richman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric I Richman owns 4 companies in total, including NeuBase Therapeutics Inc (NBSE) , ADMA Biologics Inc (ADMA) , and Altimmune Inc (ALT) among others .
Click here to see the complete history of Eric I Richman’s form 4 insider trades.
Insider Ownership Summary of Eric I Richman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NBSE | NeuBase Therapeutics Inc | 2022-03-04 | director |
ADMA | ADMA Biologics Inc | 2018-06-08 | director |
ALT | Altimmune Inc | 2009-01-21 | SVP & Business Development |
2024-07-01 | director |
Eric I Richman Latest Holdings Summary
Eric I Richman currently owns a total of 3 stocks. Among these stocks, Eric I Richman owns 36,530 shares of ADMA Biologics Inc (ADMA) as of June 8, 2018, with a value of $795,623 and a weighting of 55.69%. Eric I Richman owns 304,458 shares of Gain Therapeutics Inc (GANX) as of July 1, 2024, with a value of $631,750 and a weighting of 44.22%. Eric I Richman also owns 3,635 shares of NeuBase Therapeutics Inc (NBSE) as of March 4, 2022, with a value of $1,374 and a weighting of 0.1%.
Latest Holdings of Eric I Richman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ADMA | ADMA Biologics Inc | 2018-06-08 | 36,530 | 21.78 | 795,623 |
GANX | Gain Therapeutics Inc | 2024-07-01 | 304,458 | 2.08 | 631,750 |
NBSE | NeuBase Therapeutics Inc | 2022-03-04 | 3,635 | 0.38 | 1,374 |
Holding Weightings of Eric I Richman
Eric I Richman Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric I Richman has made a total of 0 transactions in ADMA Biologics Inc (ADMA) over the past 5 years. The most-recent trade in ADMA Biologics Inc is the acquisition of 5,230 shares on June 8, 2018, which cost Eric I Richman around $24,999.
According to the SEC Form 4 filings, Eric I Richman has made a total of 4 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 17,000 shares on July 1, 2024, which cost Eric I Richman around $20,740.
According to the SEC Form 4 filings, Eric I Richman has made a total of 2 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 194 shares on March 4, 2022, which cost Eric I Richman around $6,363.
Insider Trading History of Eric I Richman
- 1
Eric I Richman Trading Performance
GuruFocus tracks the stock performance after each of Eric I Richman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric I Richman is 21.92%. GuruFocus also compares Eric I Richman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric I Richman within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric I Richman's insider trading performs compared to the benchmark.
Performance of Eric I Richman
Eric I Richman Ownership Network
Ownership Network List of Eric I Richman
Ownership Network Relation of Eric I Richman
Eric I Richman Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
Eric I Richman is the director of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, Eric I Richman made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
Eric I Richman Mailing Address
Above is the net worth, insider trading, and ownership report for Eric I Richman. You might contact Eric I Richman via mailing address: C/o Rev Capital Ii, Llc, 9740 Sorrel Ave, Potomac Md 20854.